Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA expands approval of breast cancer drug Kisqali
Major New Drug Approval For Preventing Recurrence In Early Stage Breast Cancer Patients: Weighing The Risks & Benefits of Kisqali
The Food and Drug Administration (FDA) has just approved the drug Kisqali (ribociclib) in combination with an aromatase inhibitor (AI) as treatment for people with HR+/HER2- stage II and III early breast cancer (EBC) at high risk of recurrence.
Kisqali wins FDA nod for breast cancer treatment: Dosage, effectiveness and side effects of the breakthrough drug
The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It targets high-risk HR-posit
Novartis’ Kisqali receives FDA approval to reduce the risk of breast cancer recurrence
Novartis announced this week that the FDA has approved ribociclib (marketed as Kisqali) for the treatment of people with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR-positive,
Targeted Oncology
2d
Ribociclib-Based Therapy Extends Survival in HR+/HER2– Breast Cancer
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...
The American Journal of Managed Care
4d
FDA Approves Ribociclib for Early Breast Cancer Treatment With High Recurrence Rate
The FDA approved
ribociclib
(
Kisqali
) for adjuvant treatment of high-risk, hormone receptor-positive, HER2-negative early breast cancer. The FDA approved
ribociclib
(
Kisqali
) with an aromatase ...
pharmaphorum
3d
Lilly on alert as new Kisqali approval threatens Verzenio
Novartis' CDK4/6 inhibitor Kisqali has claimed a broad FDA approval in early breast cancer that could give it an edge over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Secret Service admits failure
Kentucky judge fatally shot
Secret Service probing post
Sesame Place suit verdict
Boeing defense chief exits
$230 million crypto theft
Drug price challenge revived
Body found in SUV
Russia threatens retaliation
Jurors begin deliberations
SC 1st execution in 13 years
Whooping cough cases spike
FDA approves flu vaccine
Pandas leaving for China
WI high court to decide
Feds subpoena Schaeffer
Disney to stop using Slack
Hand count approved in GA
144K+ Mavericks recalled
Bill to boost security OK'd
Raises settlement offer
In-person voting begins
House repeals emission rules
Top Hezbollah leader killed?
Sues pharmacy middlemen
Stein's ballot bid rejected
Baby powder recalled
$3B for battery projects
MS sheriff's office probe
Recalling 449K+ vehicles
1st rabies outbreak in seals
Related topics
Food and Drug Administration
Breast cancer
Feedback